Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staccato Loxapine for Agitation in Schizophrenia or Bipolar Disorder
NCT04148963Phase 3Unknown
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Dec 2019
- Primary completion
- May 2020
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of loxapine in psychomotor agitation, sponsored by Lee's Pharmaceutical Holdings Limited. Status: unknown.
02
Drugs
loxapine
03
Conditions
psychomotor agitation
Beyond the preview
Go deeper on NCT04148963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04148963.